Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancer.
A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancer. Clin Genitourin Cancer. 2008 Mar; 6(1):21-4.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Benzamides
Carcinoma, Papillary
Carcinoma, Renal Cell
Chicago
Dose-Response Relationship, Drug
Female
Humans
Kidney Neoplasms
Male
Middle Aged
Prognosis
Quinazolines
Safety
Universities
authors with profiles
Walter M. Stadler